TWST price target
Twist Bioscience Corporation · end-of-day data as of Nov 13, 2026
Twist Bioscience
$111.60-2.3%
PT $145.70 +30.6%▲ 3
- PT$145.70 +30.6%
- ConsensusBuy · 13
- Sector▲ +15.9%
Neutral
- Earnings in80d
- RSI38
- Support-50.2%
- Resistance+55.4%
- Off 52w high-49.2%
- Volume0.8x
- Bollingerlower half
- News1.00
- Trendsideways
- 52w range$23–$220
- ATR+15.1%
- Off ATH-49.2%
▼ 4
- Insiders-$99.86M
- MAs1 of 4
- MA20×50Death 9d ago
- MACD-3.21
Updates with the 15-min delayed price. Not a forecast or investment advice.
Summary
- Price target at+30.6%
- ConsensusBuy
Analyst price targets
10 firms with a target in the last 12 months · last close $111.60 · as of Nov 13, 2026
— actual price● bullish target● bearish target┄ last close, high, average and low targethover a dot to see the analysts behind it ·wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets
Evercore ISI$422026-01-05
Barclays$392025-12-15
Barclays$502026-02-03
Evercore ISI$522026-02-03
Robert W. Baird$502026-02-03
Guggenheim$602026-05-05
Robert W. Baird$652026-05-05
Barclays$652026-05-04
Barclays$552026-04-14
Evercore ISI$1022026-07-06
Barclays$952026-06-24
Canaccord Genuity$902026-06-15
Cowen & Co.$892026-06-15
Piper Sandler$852026-06-11
Leerink Partners$802026-05-22
Piper Sandler$1152026-08-05
Robert W. Baird$1152026-08-04
Leerink Partners$1102026-07-16
Canaccord Genuity$1202026-07-14
Guggenheim$1072026-06-29
Jefferies$1502026-10-08
Leerink Partners$1602026-09-17
UBS$1442026-09-09
Canaccord Genuity$2052026-10-12
Barclays$2152026-10-07
Guggenheim$2122026-10-01
Leerink Partners$1902026-09-29
Canaccord Genuity$1502026-11-13
Jefferies$1252026-11-12
Strong buy 2Buy 7Hold 3Sell 1Strong sell 0
13 analysts in November 2026: 9 rate it a buy or strong buy (69%), 3 a hold and 1 a sell or strong sell. A year earlier, 89% rated it a buy or strong buy.